Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome

J Dermatol. 2018 Jan;45(1):95-99. doi: 10.1111/1346-8138.14033. Epub 2017 Sep 19.

Abstract

Angiogenesis is an important step to support progression of malignancies, including mycosis fungoides (MF) and Sézary syndrome (SS). Vascular endothelial growth factor (VEGF)-A, a key player in angiogenesis, is secreted by tumor cells of MF/SS and its expression levels in lesional skin correlated with disease severity. In this study, we examined serum VEGF-A levels in MF/SS patients. Serum VEGF-A levels were elevated in patients with erythrodermic MF/SS and the levels decreased after treatment. Importantly, serum VEGF-A levels positively correlated with markers for pruritus. We also found that VEGF-A upregulated mRNA expression of thymic stromal lymphopoietin by keratinocytes. Taken together, our study suggests that VEGF-A can promote progression and pruritus in MF/SS. Inhibition of VEGF-A signaling can be a therapeutic strategy for patients with erythrodermic MF/SS.

Keywords: cutaneous T-cell lymphoma; epidermal keratinocytes; pruritus; thymic stromal lymphopoietin; vascular endothelial growth factor A.

MeSH terms

  • Aged
  • Case-Control Studies
  • Cell Line
  • Cytokines / metabolism
  • Female
  • Humans
  • Keratinocytes / metabolism
  • Male
  • Middle Aged
  • Mycosis Fungoides / blood*
  • Mycosis Fungoides / complications
  • Pruritus / blood*
  • Pruritus / etiology
  • Sezary Syndrome / blood*
  • Sezary Syndrome / complications
  • Thymic Stromal Lymphopoietin
  • Vascular Endothelial Growth Factor A / blood*
  • Vascular Endothelial Growth Factor C / blood*

Substances

  • Cytokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor C
  • Thymic Stromal Lymphopoietin